Postoperative bleeding in a patient with normal screening coagulation tests

American Journal of the Medical Sciences

Volumn 342, Issue 3, 2011, Pages 262-264

  Nourbakhsh, Eva ^a   Anvari, Reza ^a   D'Cunha, Nicholas ^a   Thaxton, Lauren ^a   Malik, Asim ^a   Nugent, Kenneth ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Bleeding; Coagulation factors; Cryoprecipitate; Factor XIII

Indexed keywords

BLOOD CLOTTING FACTOR 13; ENOXAPARIN; HEMOGLOBIN; PLASMINOGEN;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; CASE REPORT; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LABORATORY TEST; LEG INJURY; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; THROMBOCYTE COUNT; TRAFFIC ACCIDENT;

EID: 80052264681     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182246109     Document Type: Article

References (16)

1. Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia 2008;14: 1190-200.
2. Nijenhuis AV, van Bergeijk L, Huijgens PC, et al. Acquired factor XIII deficiency due to an inhibitor: A case report and review of the literature. Haematologica 2004;89:ECR14.
3. Ivaskevicius V, Windyga J. Phenotype-genotype correlation in eight Polish patients with inherited factor XIII deficiency: Identification of three novel mutations. Haemophilia 2007;13:649-57. (Pubitemid 47338011)
4. Ivaskevicius V, Seitz R. International registry on factor XIII deficiency: A basis formed mostly on European data. Thromb Haemost 2007;97:914-21. (Pubitemid 46947830)
5. Bhattacharya M, Biswas A. Clinico-hematologic profile of factor XIII-deficient patients. Clin Appl Thromb Hemost 2005;11:475-80. (Pubitemid 41546776)
6. Tyler HM. A comparative study of solvents commonly used to detect fibrin stabilization. Thromb Diath Haemorrh 1966;31:16:61-8.
7. Fear JD, Miloszewski KJ, Losowsky MS. The half life of factor XIII in the management of inherited deficiency. Thromb Haesmost 1983;49: 102-5. (Pubitemid 13124982)
8. Robberts HR, Bingham MD. Other coagulation factor deficiencies. In: Loscalzo J, Schafer AI, editors. Thrombosis and haemorrhage, 3rd ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2003. p. 592-3.
9. Lovejoy AE, Reynolds TC, Visich JE. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 2006;108:57-62.
10. Lim W, Moffat K, Hayward CP. Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency. J Thromb Haemost 2004;2:1017-9. (Pubitemid 40185756)
11. Jim RT. Factor XIII deficiency (fibrin stabilizing factor). Hawaii Med J 2008;67:270-1, 273.
12. Halverstadt A, Walsh S, Roth SM, et al. Identification of a novel mutation combination in factor XIII deficiency: Genetic update to the first reported case in the United States. Int J Hematol 2006;83: 144-6. (Pubitemid 44227960)
13. Lorand L, Velasco PT, Murthy SN, et al. Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner. Blood 1999;93:909-17. (Pubitemid 29067856)
14. Krumdieck R, Shaw DR, Huang ST, et al. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. Am J Med 1991;90:639-45.
15. Thakker S, McGehee W, Quismorio FP Jr. Arthropathy associated with factor XIII deficiency. Arthritis Rheum 1986;29:808-11.
16. Petri M, Ellman L, Carey R. Acquired factor XIII deficiency with chronic myelomonocytic leukemia. Ann Intern Med 1983;99:638-9. (Pubitemid 14235402)